NEW AND IMPROVED FLAT/SLIDING FEE PROGRAM. For more information click on learn more or contact our office at 843-309-8301.
We no longer can provide Monoclonal Antibody Infusion due to the FDA withdrawal of the approval.
In nonhospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease, Remdesivir should be started within 7 days of symptom onset and administered for 3 days.
For more information, please contact our IV Therapy Department at 843.758.0044